BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 19028780)

  • 1. Lack of benefit from percutaneous intervention of persistently occluded infarct arteries after the acute phase of myocardial infarction is time independent: insights from Occluded Artery Trial.
    Menon V; Pearte CA; Buller CE; Steg PG; Forman SA; White HD; Marino PN; Katritsis DG; Caramori P; Lasevitch R; Loboz-Grudzien K; Zurakowski A; Lamas GA; Hochman JS
    Eur Heart J; 2009 Jan; 30(2):183-91. PubMed ID: 19028780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of outcome and the lack of effect of percutaneous coronary intervention across the risk strata in patients with persistent total occlusion after myocardial infarction: Results from the OAT (Occluded Artery Trial) study.
    Kruk M; Kadziela J; Reynolds HR; Forman SA; Sadowski Z; Barton BA; Mark DB; Maggioni AP; Leor J; Webb JG; Kapeliovich M; Marin-Neto JA; White HD; Lamas GA; Hochman JS
    JACC Cardiovasc Interv; 2008 Oct; 1(5):511-20. PubMed ID: 19194534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of timing, location and definition of reinfarction on mortality in patients with totally occluded infarct related arteries late after myocardial infarction.
    Adlbrecht C; Huber K; Reynolds HR; Carvalho AC; Džavík V; Steg PG; Liu L; Marino P; Pearte CA; Rankin JM; White HD; Lamas GA; Hochman JS
    Int J Cardiol; 2014 Jun; 174(1):90-5. PubMed ID: 24726166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Late coronary intervention for totally occluded left anterior descending coronary arteries in stable patients after myocardial infarction: Results from the Occluded Artery Trial (OAT).
    Malek LA; Reynolds HR; Forman SA; Vozzi C; Mancini GB; French JK; Dziarmaga M; Renkin JP; Kochman J; Lamas GA; Hochman JS
    Am Heart J; 2009 Apr; 157(4):724-32. PubMed ID: 19332202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized trial of percutaneous coronary intervention for subacute infarct-related coronary artery occlusion to achieve long-term patency and improve ventricular function: the Total Occlusion Study of Canada (TOSCA)-2 trial.
    Dzavík V; Buller CE; Lamas GA; Rankin JM; Mancini GB; Cantor WJ; Carere RJ; Ross JR; Atchison D; Forman S; Thomas B; Buszman P; Vozzi C; Glanz A; Cohen EA; Meciar P; Devlin G; Mascette A; Sopko G; Knatterud GL; Hochman JS;
    Circulation; 2006 Dec; 114(23):2449-57. PubMed ID: 17105848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electrophysiological effects of late percutaneous coronary intervention for infarct-related coronary artery occlusion: the Occluded Artery Trial-Electrophysiological Mechanisms (OAT-EP).
    Rashba EJ; Lamas GA; Couderc JP; Hollist SM; Dzavik V; Ruzyllo W; Fridrich V; Buller CE; Forman SA; Kufera JA; Carvalho AC; Hochman JS;
    Circulation; 2009 Feb; 119(6):779-87. PubMed ID: 19188505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship of female sex to outcomes after myocardial infarction with persistent total occlusion of the infarct artery: analysis of the Occluded Artery Trial (OAT).
    Reynolds HR; Forman SA; Tamis-Holland JE; Steg PG; Mark DB; Pearte CA; Carvalho AC; Sopko G; Liu L; Lamas GA; Kruk M; Loboz-Grudzien K; Ruzyllo W; Hochman JS
    Am Heart J; 2012 Mar; 163(3):462-9. PubMed ID: 22424018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Percutaneous revascularization and long term clinical outcomes of diabetic patients randomized in the Occluded Artery Trial (OAT).
    Overgaard CB; Džavík V; Buller CE; Liu L; Banasiak W; Devlin G; Maggioni AP; Leor J; Burton JR; Reis G; Ruzyllo W; Forman SA; Lamas GA; Hochman JS;
    Int J Cardiol; 2013 Oct; 168(3):2416-22. PubMed ID: 23582414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Percutaneous coronary intervention in the Occluded Artery Trial: procedural success, hazard, and outcomes over 5 years.
    Buller CE; Rankin JM; Carere RG; Buszman PE; Pfisterer ME; Dzavik V; Thomas B; Forman S; Ruzyllo W; Mancini GB; Michalis LK; Abreu PF; Lamas GA; Hochman JS
    Am Heart J; 2009 Sep; 158(3):408-15. PubMed ID: 19699864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Causes of death in early MI survivors with persistent infarct artery occlusion: results from the Occluded Artery Trial (OAT).
    Lang IM; Forman SA; Maggioni AP; Ruzyllo W; Renkin J; Vozzi C; Steg PG; Hernandez-Garcia JM; Zmudka K; Jimenez-Navarro M; Sopko G; Lamas GA; Hochman JS
    EuroIntervention; 2009 Nov; 5(5):610-8. PubMed ID: 20142183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term effects of percutaneous coronary intervention of the totally occluded infarct-related artery in the subacute phase after myocardial infarction.
    Hochman JS; Reynolds HR; Dzavík V; Buller CE; Ruzyllo W; Sadowski ZP; Maggioni AP; Carvalho AC; Rankin JM; White HD; Goldberg S; Forman SA; Mark DB; Lamas GA;
    Circulation; 2011 Nov; 124(21):2320-8. PubMed ID: 22025606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heart failure in post-MI patients with persistent IRA occlusion: prevalence, risk factors, and the long-term effect of PCI in the Occluded Artery Trial (OAT).
    Jhaveri RR; Reynolds HR; Katz SD; Jeger R; Zinka E; Forman SA; Lamas GA; Hochman JS
    J Card Fail; 2012 Nov; 18(11):813-21. PubMed ID: 23141853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution and determinants of myocardial perfusion grade following late mechanical recanalization of occluded infarct-related arteries postmyocardial infarction: a report from the occluded artery trial.
    Jorapur V; Steigen TK; Buller CE; Dzavík V; Webb JG; Strauss BH; Yeoh EE; Kurray P; Sokalski L; Machado MC; Kronsberg SS; Lamas GA; Hochman JS; Mancini GB
    Catheter Cardiovasc Interv; 2008 Nov; 72(6):783-9. PubMed ID: 18798327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reinfarction after percutaneous coronary intervention or medical management using the universal definition in patients with total occlusion after myocardial infarction: results from long-term follow-up of the Occluded Artery Trial (OAT) cohort.
    White HD; Reynolds HR; Carvalho AC; Pearte CA; Liu L; Martin CE; Knatterud GL; Džavík V; Kruk M; Steg PG; Cantor WJ; Menon V; Lamas GA; Hochman JS
    Am Heart J; 2012 Apr; 163(4):563-71. PubMed ID: 22520521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of stress testing before percutaneous coronary intervention or medical management on outcomes of patients with persistent total occlusion after myocardial infarction: analysis from the occluded artery trial.
    Cantor WJ; Baptista SB; Srinivas VS; Pearte CA; Menon V; Sadowski Z; Ross JR; Meciar P; Nikolsky E; Forman SA; Lamas GA; Hochman JS
    Am Heart J; 2009 Apr; 157(4):666-72. PubMed ID: 19332193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infarct artery distribution and clinical outcomes in occluded artery trial subjects presenting with non-ST-segment elevation myocardial infarction (from the long-term follow-up of Occluded Artery Trial [OAT]).
    Menon V; Ruzyllo W; Carvalho AC; Almeida de Sousa JM; Forman SA; Jaworska K; Lamas GA; Roik M; Thuaire C; Turgeman Y; Hochman JS
    Am J Cardiol; 2013 Apr; 111(7):930-5. PubMed ID: 23351464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of short-term symptomatic benefit in patients with an occluded infarct artery is unrelated to non-protocol revascularization: results from the Occluded Artery Trial (OAT).
    Devlin G; Reynolds HR; Mark DB; Rankin JM; Carvalho AC; Vozzi C; Sopko G; Caramori P; Džavík V; Ragosta M; Forman SA; Lamas GA; Hochman JS
    Am Heart J; 2011 Jan; 161(1):84-90. PubMed ID: 21167338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of infarct artery patency on prognosis after acute myocardial infarction. The Survival and Ventricular Enlargement Investigators.
    Lamas GA; Flaker GC; Mitchell G; Smith SC; Gersh BJ; Wun CC; Moyé L; Rouleau JL; Rutherford JD; Pfeffer MA
    Circulation; 1995 Sep; 92(5):1101-9. PubMed ID: 7648653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Occluded Artery Trial (OAT) Viability Ancillary Study (OAT-NUC): influence of infarct zone viability on left ventricular remodeling after percutaneous coronary intervention versus optimal medical therapy alone.
    Udelson JE; Pearte CA; Kimmelstiel CD; Kruk M; Kufera JA; Forman SA; Teresinska A; Bychowiec B; Marin-Neto JA; Höchtl T; Cohen EA; Caramori P; Busz-Papiez B; Adlbrecht C; Sadowski ZP; Ruzyllo W; Kinan DJ; Lamas GA; Hochman JS
    Am Heart J; 2011 Mar; 161(3):611-21. PubMed ID: 21392619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delayed post-myocardial infarction invasive measures, helpful or harmful? A subgroup analysis.
    Yip HK; Wu CJ; Yang CH; Chang HW; Chen SM; Hung WC; Hang CL
    Chest; 2004 Jul; 126(1):38-46. PubMed ID: 15249440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.